Sarah Cavanaugh

Insider Reports History

Entity
Individual
Location
C/O Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ
Signature
/s/ Sam Martin, attorney-in-fact for Sarah Cavanaugh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah Cavanaugh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Celldex Therapeutics, Inc. SVP OF CORP AFFAIRS & ADMIN. Common Stock 1.86K $62.7K $33.73 May 30, 2024 Direct
Celldex Therapeutics, Inc. SVP OF CORP AFFAIRS & ADMIN. Incentive Stock Option (right to buy) 78K Jun 13, 2024 Direct

Insider Reports Filed by Sarah Cavanaugh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLDX Celldex Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 SVP OF CORP AFFAIRS & ADMIN.
CLDX Celldex Therapeutics, Inc. May 30, 2024 5 -$582K 4 Jun 3, 2024 SVP OF CORP AFFAIRS & ADMIN.
CLDX Celldex Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 SVP OF CORP AFFAIRS & ADMIN.
CLDX Celldex Therapeutics, Inc. Aug 17, 2022 6 -$1.1M 4 Aug 19, 2022 SVP OF CORP AFFAIRS & ADMIN.
CLDX Celldex Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 SVP OF CORP AFFAIRS & ADMIN.
CLDX Celldex Therapeutics, Inc. Dec 8, 2021 5 -$219K 4 Dec 10, 2021 SVP of Corp Affairs & Admin.
CLDX Celldex Therapeutics, Inc. Nov 1, 2021 7 -$269K 4 Nov 3, 2021 SVP of Corp Affairs & Admin.
CLDX Celldex Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 SVP of Corp Affairs & Admin.